Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · IEX Real-Time Price · USD
1.120
+0.030 (2.75%)
At close: Jul 26, 2024, 4:00 PM
1.099
-0.021 (-1.88%)
After-hours: Jul 26, 2024, 6:04 PM EDT
Gossamer Bio Market Cap
Gossamer Bio has a market cap or net worth of $253.37 million as of July 26, 2024. Its market cap has increased by 59.95% in one year.
Market Cap
253.37M
Enterprise Value
217.64M
1-Year Change
59.95%
Ranking
Category
Stock Price
$1.12
Market Cap Chart
Since February 8, 2019, Gossamer Bio's market cap has decreased from $1.08B to $253.37M, a decrease of -76.62%. That is a compound annual growth rate of -23.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 246.60M | 19.94% |
| Dec 29, 2023 | 205.60M | 0.29% |
| Dec 30, 2022 | 205.00M | -76.30% |
| Dec 31, 2021 | 864.80M | 17.79% |
| Dec 31, 2020 | 734.20M | -28.87% |
| Dec 31, 2019 | 1.03B | -4.74% |
| Feb 8, 2019 | 1.08B | - |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeuroPace | 258.63M |
| Atai Life Sciences | 257.82M |
| Immutep | 253.60M |
| Cibus | 252.84M |
| Nanobiotix | 252.28M |
| Tectonic Therapeutic | 251.01M |
| Sera Prognostics | 249.69M |
| Senseonics Holdings | 248.08M |